Guidelines for the Management of Dyspepsia

@article{Talley2005GuidelinesFT,
  title={Guidelines for the Management of Dyspepsia},
  author={Nicholas J. Talley and Nimish Vakil},
  journal={The American Journal of Gastroenterology},
  year={2005},
  volume={100},
  pages={2324-2337}
}
  • N. Talley, N. Vakil
  • Published 1 October 2005
  • Medicine
  • The American Journal of Gastroenterology
Dyspepsia is a chronic or recurrent pain or discomfort centered in the upper abdomen; patients with predominant or frequent (more than once a week) heartburn or acid regurgitation, should be considered to have gastroesophageal reflux disease (GERD) until proven otherwise. Dyspeptic patients over 55 yr of age, or those with alarm features should undergo prompt esophagogastroduodenoscopy (EGD). In all other patients, there are two approximately equivalent options: (i) test and treat for… 

Figures and Tables from this paper

Current treatments in functional dyspepsia

TLDR
Empiric acid suppression with H2-receptor antagonists or proton-pump inhibitors is superior to placebo in treatment of FD, but those patients with meal-related symptoms are least likely to respond.

How to manage the difficult-to-treat dyspeptic patient

  • N. Talley
  • Medicine
    Nature Clinical Practice Gastroenterology &Hepatology
  • 2007
TLDR
The difficult-to-treat patient with functional dyspepsia has already had Helicobacter pylori infection excluded or eradicated, has failed to respond to an adequate trial of acid-suppression therapy that used appropriate doses and, therefore, seeks other solutions.

Investigating dyspepsia

TLDR
An overview of current guidelines and recommendations is provided and recent evidence from systematic reviews and clinical trials is reported, indicating that appropriate management is essential to reduce costs.

What is the optimal therapy for patients with Helicobacter pylori-negative dyspepsia?

  • R. SaadW. Chey
  • Medicine
    Nature Clinical Practice Gastroenterology &Hepatology
  • 2006
TLDR
Patients with dyspepsia (epigastric pain with or without concomitant symptoms), considered by a family physician to be suitable for therapy, were enrolled in this double-blind, multicenter, paralleldesign study.

Evidence-Based Approach to Dyspepsia: From Helicobacter pylori to Functional Disease

TLDR
Functional dyspepsia is best managed using a multifaceted approach by establishing a good physician-patient relationship, dietary and lifestyle interventions, medical therapy, psychotherapy, and the use of psychotropic medications.

Dyspepsia and Helicobacter pylori

TLDR
The main therapeutic strategy for managing dyspepsia in patients under the age of 45 years is ‘test and treat’ and H. pylori eradication therapy gives modest but significant benefit in non-ulcer dyspeptic patients and leads to long-term symptom improvement.

Case Series on Persistant Dyspepsia Even After Treatment with Proton Pump Inhibitors

TLDR
5 cases who were treated on proton pump inhibitors on detailed investigations revealed an alternative cause for dyspepsia, and the authors aim to clarify the Pathophysiology, definition, diagnostic techniques and treatment of patients with heartburn symptoms who symptoms of dyspePSia continues even after treatment with PPI (rabeprazole).

Clinical Practice: Diagnosis and Evaluation of Dyspepsia

TLDR
Despite the ability to successfully cure H. pylori infections, a symptomatic response can be expected in only a minority of those with dyspepsia not associated with ulcers, and symptomatic relief is often difficult to achieve.

An Evidence-Based Approach to the Management of Functional Dyspepsia Associated With Helicobacter pylori Infection

TLDR
Investigation among a Chinese population in Taiwan found cases with functional dyspepsia have the characteristics of middle age, female predominance, a relatively lower H. pylori infection rate and a positive response to H.pylori eradication therapy.

Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial

  • Mohammed Q. Khan
  • Medicine
    Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
  • 2008
TLDR
An updated systematic review suggests that H. pylori eradication has a small but statistically significant benefit in treating non-ulcer dyspepsia (NUD), and shows that it is beneficial and cost-effective in treating NUD.
...

References

SHOWING 1-10 OF 141 REFERENCES

Therapy for Helicobacter pylori in Patients with Nonulcer Dyspepsia

TLDR
A systematic review of H. pylori eradication therapy in patients with nonulcer dyspepsia to determine whether H.pylori therapy is significantly better than control therapy.

Management Strategies for Helicobacter pylori-Seropositive Patients with Dyspepsia: Clinical and Economic Consequences

TLDR
Alternative strategies for the initial management of dyspepsia are outlined, which include initial endoscopy, empirical anti-H.

Dyspepsia management in primary care: a decision analysis of competing strategies.

TLDR
Patients younger than 45 with dyspepsia and without “alarm” symptoms should be tested for H. pylori and, if positive, receive a 10to 14-day course of eradication therapy, and if symptoms fail to improve with treatment, then diagnostic upper endoscopy should be performed.

Guidelines for the management of dyspepsia.

TLDR
A diagnosis of gastrooesophageal reflux disease can now be made confidently by endoscopy, with selective use of 24 h pH study of the lower oesophagus, and evidence is beginning to emerge that further stratification of dyspeptics on the basis of symptoms and other risk factors may help in management.

Guidelines for the management of dyspepsia.

TLDR
A diagnosis of gastrooesophageal reflux disease can now be made confidently by endoscopy, with selective use of 24 h pH study of the lower oesophagus, and evidence is beginning to emerge that further stratification of dyspeptics on the basis of symptoms and other risk factors may help in management.

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori

TLDR
The management tool has 5 key decision steps addressing the following: evidence that symptoms originate in the upper gastrointestinal tract, presence of alarm features, use of nonsteroidal anti-inflammatory drugs (NSAIDs), dominant reflux symptoms and evidence of Helicobacter pylori infection.

Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern.

TLDR
Patients with FD responding to omeprazole were characterized by many reflux episodes, and this double-blind trial compares the number ofReflux episodes in responders and non-responders to omEPrazole.

Therapeutic Options in Nonulcer Dyspepsia

  • N. Talley
  • Medicine
    Journal of clinical gastroenterology
  • 2001
TLDR
Although cisapride relieves symptoms of dyspepsia without the adverse central nervous system effects often associated with metoclopramide, its cardiac toxicity has led to disuse and new prokinetics and other enteric neuromodulating agents are being tested in NUD and are likely to find an important place in clinical practice in the future.

Dyspepsia in primary care: acid suppression as effective as prokinetic therapy. A randomized clinical trial.

TLDR
Antisecretory and prokinetic therapies are equally effective in primary care patients with uninvestigated dyspeptic complaints, though relapse rates are lower in patients treated with prokinetics.
...